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Abstract 
As part of measles elimination effort, evaluation of the vaccination program and real-time 
assessment  of  the  epidemic  dynamics  constitute  two  important  tasks  to  improve  and 
strengthen the control. The present study aimed to develop an epidemiological modeling 
method which can be applied to estimating the vaccine efficacy at an individual level while 
conducting the timely investigation of the epidemic. The multivariate renewal process model 
was employed to describe the temporal evolution of infection by vaccination history, jointly 
estimating the time-dependent reproduction number and the vaccine efficacy. Analyzing the 
enhanced surveillance data of measles in Aichi prefecture, Japan from 2007-08, the vaccine 
efficacy was estimated at 96.7% (95% confidence interval: 95.8, 97.4). Using an age structured 
model, the vaccine efficacy among those aged from 5-19 years was shown to be smaller than 
that among those from 0-4 years. The age-dependent vaccine efficacy estimate informs the 
age-groups to be targeted for revaccination. Because the estimation method can rest on 
readily available epidemiological data, the proposed model has a potential to be integrated 
with routine surveillance. 
Key words: vaccination, epidemiology, measles, mathematical model, vaccine efficacy. 
Introduction 
Although  the  World  Health  Organization 
(WHO) and its member states across the world have 
aimed to eliminate measles, the elimination has been 
so  far  fully  successful  only  in  the  North  American 
region.  As  the  transmission  potential  of  measles  is 
extremely high with the estimated basic reproduction 
number  of  the  order  of  6-45  [1-4],  i.e.  the  average 
number  of  secondary  cases  generated  by  a  single 
primary case in a fully susceptible population being 
6-45, it is necessary to maintain very high vaccination 
coverage to eliminate the infection by means of mass 
vaccination.  In  industrialized  countries,  all  children 
are subject to routine immunization mostly by the age 
of 18 months using either MR (measles and rubella) or 
MMR (measles, mumps and rubella) vaccine. Moreo-
ver, to boost the vaccine-induced immunity, children 
aged from 4-5 years receive the second dose, and de-
pending  on  each  individual  country’s  policy,  addi-
tional doses/revaccinations are scheduled. 
Understanding  the  vaccine  efficacy  at  an  indi-
vidual level is essential to assess the vaccination pro-
gram. Although the vaccine efficacy against measles is 
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believed to be high (e.g. >95%) [5], in practice even 
vaccinated individuals may be susceptible if the vac-
cination failure occurred or if their vaccine-induced 
immunity waned [6]. If the evaluation can be made 
based on readily available epidemiological datasets in 
real-time, disease control policy making will be able to 
reflect the results of such analysis. For instance, if we 
can detect the signature of a potential major epidemic 
in  near  future  [7]  or  if  we  can  identify  specific 
sub-populations that are less protected than others [8], 
the  epidemiological  modeling  study  could  improve 
real-time policy making, e.g. identifying an essential 
part of the population to be (re-)vaccinated. 
To  estimate  the  vaccine  efficacy,  three  distinct 
study approaches have been taken. First, laboratory 
measurement (e.g. seroconversion) has been used as a 
surrogate marker of successful immunization, allow-
ing  us  to  judge  the  vaccine-induced  immunity  in  a 
biologically  well-defined  manner.  However,  such 
measurement requires laboratory test samples as well 
as  testing  capacity,  and  perhaps  more  importantly, 
makes it difficult to directly attribute the result to ac-
tual  vaccine-induced  protection  (e.g.  actual  causal 
impact  of  vaccination  against  infection)  at  an  indi-
vidual level [9,10]. Other two approaches thus tackle 
the  issue  of  assessment  using  epidemiological  data. 
Since the epidemiological data of directly transmitted 
infectious diseases involve the technical problem  of 
dependent risk of infection between individuals (i.e. 
the  so-called  “dependent  happening”),  the  empiri-
cally observed datasets are greatly influenced by the 
indirect  effect  of  vaccination  [11].  Therefore,  as  the 
second method, the conditional risks of infection (i.e. 
conditional on an exposure to an infected individual) 
in vaccinated and unvaccinated individuals are com-
pared to estimate the conditional direct effect of vac-
cination while reasonably eliminating the influence of 
indirect  effect.  For  instance,  household  secondary 
attack proportion (SAP) is conventionally used to es-
timate the efficacy using the conditional risk of infec-
tion  given a primary case in households. However, 
collection  of  household  transmission  data  requires 
substantial  observational  effort  and  moreover,  such 
study needs to ensure uniform susceptibility among 
household contacts. As the third method, the popula-
tion  data  may  be  analyzed  by  employing  a  mathe-
matical model that can be believed to have captured 
the underlying transmission dynamics. In particular, 
the final size of an epidemic (i.e. the fraction of the 
total infected individuals in a population throughout 
the course of an epidemic) has been used to estimate 
the  efficacy  in  a  highly  vaccinated  population 
[1,12,13].  However,  there  has  been  little  attempt  to 
estimate the vaccine efficacy jointly with the epidemic 
dynamics  in  real-time  (e.g.  during  the  course  of  an 
epidemic). 
The present study aims to propose an epidemi-
ological method which we can employ to estimate the 
vaccine efficacy of measles while conducting real-time 
assessment of the epidemic based on readily available 
epidemiological  surveillance  datasets.  While  not  re-
quiring us to conduct field investigations to specifi-
cally  assess  the  vaccine  efficacy,  we  show  that  the 
assessment can be partly achieved by analyzing the 
counts of cases with vaccination history over time. 
Materials and Methods 
Epidemiological data 
The  present  study  investigates  empirical  data 
from Aichi prefecture, around the middle of  Japan, 
which  has  a  mild  temperate  climate  and  has  long 
served  as  an  intersection  between  the  cultures  of 
eastern  and  western  Japan.  In  Japan,  children  aged 
from 12-24 months had received a single-dose MMR 
vaccination from 1988 to 1993. MMR vaccine was re-
placed by MR vaccine in 1993 due to the reporting of 
the substantial number of abacterial meningitis cases 
that  were  attributed  to  MMR  vaccination,  lowering 
the overall vaccination coverage for a while. In 2006, 
the  country  initiated  the  two-dose  vaccination  pro-
gram in which first and second doses are given at the 
age  of  12-24  months  and  before  entering  primary 
schools (i.e. before the age of 6 years), respectively. 
Despite nationwide vaccination campaigns, the vac-
cination coverage remained insufficient to prevent the 
epidemic  of  measles,  and  only  in  recent  years,  the 
vaccination coverage of the first dose clearly exceeded 
95.0% which is believed as the minimum coverage to 
eliminate  a  disease  given  the  basic  reproduction 
number  of  20.  Due  to  the  presence  of  the  various 
pockets  of  susceptible  individuals,  sporadic  minor 
outbreaks have been seen continuously across Japan. 
To monitor the outbreaks and strengthen the measles 
control, the Ministry of Health, Labour and Welfare of 
Japan has enhanced the  measles surveillance  which 
enforced  compulsory  reporting  of  all  measles  cases 
since 2008. Our study rests on the pilot data of the 
enhanced surveillance in Aichi prefecture in 2007 and 
2008. Aichi prefecture was specifically selected as the 
subject in the present  study, because the prefecture 
voluntarily  launched  the  enhanced  surveillance  in 
collaboration  with  local  medical  doctors  association 
and this was among the earliest in Japan. 
During the surveillance, the confirmed measles 
cases were defined as follows: (condition i) the cases 
who reveal all three specific signs and symptoms (i.e. 
rash,  fever  and  catarrh  including  coughing,  nasal Int. J. Biol. Sci. 2012, 8 
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discharge and congestion of conjunctiva) with (condi-
tion ii) laboratory diagnosis based either on (a) isola-
tion of the virus, (b) isolation of the virus RNA, or (c) 
serological diagnosis (i.e. seroconversion of IgM an-
tibody using paired sera). Isolation of confirmed cases 
and contact tracing of all known contacts have been 
made upon confirmatory diagnosis of each case. 
The population size of Aichi prefecture in 2007 
was  approximately  7.3  million  [14].  The  enhanced 
surveillance data included the information regarding 
the  date  of  illness  onset  (date  of  fever  and  date  of 
rash), age and vaccination history. Hereafter, we con-
sistently  use  only  the  date  of  fever  to  describe  the 
temporal patterns. In 2007 and 2008, the totals of 212 
and 198 confirmed measles cases were reported, re-
spectively.  Due  to  the  enhanced  surveillance,  these 
numbers  correspond  to  the  actual  total  numbers  of 
measles diagnoses in Aichi prefecture. Counting from 
1st January in each year, the epidemic in these years 
revealed a single peak around Days 150 and 125, re-
spectively. A part of the confirmed cases did not re-
member  their  own  vaccination  history  in  the  past 
against measles. In 2007, there were 57 vaccinated and 
87  unvaccinated  cases  that  clearly  remembered  the 
vaccination history, while 68 cases did not remember 
vaccination history. In 2008, there were 50 vaccinated 
and  86  unvaccinated  cases  with  62  cases  without 
known vaccination history. 
Mathematical model 1: Homogeneous popu-
lation 
To  develop  a  real-time  estimation  framework, 
we first consider a model to describe the transmission 
dynamics  of  measles  in  a  homogeneously  mixing 
population. Let p and  be the vaccination coverage 
and  vaccine  efficacy,  respectively.  Usually,  the  vac-
cination coverage is known, and in the case of Aichi 
prefecture, the baseline coverage of the first dose has 
been  estimated  at  94.8%  [15],  while  as  sensitivity 
analysis we estimate the vaccine efficacy by varying 
the coverage from 90.0 to 99.5%. Let k and l represent 
the vaccination history of an exposed individual and 
the primary case, respectively, for which 1 stands for 
vaccinated and 0 otherwise. We consider the renewal 
process of measles in which the incidence (the number 
of new cases) of those with vaccination history k on 
calendar day t, jk,t is described as 
, , , ,
1
, k t kl t l t
l
j A j 





       …(1) 
where  Akl,t,τ describes the rate of causing secondary 
transmissions per single primary case whose vaccine 
status is l among susceptible contacts of those with 
vaccination history k on day t at infection-age τ (i.e. 
the time since infection in each primary case). Let Ut 
represent the vaccine-unrelated frequency of second-
ary transmissions per single primary case  on day t, 
which is influenced by all factors other than vaccina-
tion including intrinsic and extrinsic ones. We assume 
that the vaccine efficacy reduces susceptibility of vac-
cinated  individuals  by  (1-)  as  was  adopted  in  an 
earlier study [12] and assume that Akl,t,τ is separable 
into the functions of t and  as follows: 
0 , ,
1 , ,
(1 ) ,
(1 ) ,
l t t
l t t
A p U g
A p U g

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

            …(2)  
where gτ is the probability mass function of the gen-
eration time, i.e. the time from infection in a primary 
case to infection in the secondary case caused by the 
primary case, and Akl,t,τ is thus assumed to be scaled 
by p,  and Ut. Based on a published statistical study 
[16], gτ is assumed to be the discrete function that is 
derived from the continuous, lognormal distribution 
with the mean and the standard deviation of 12.0 and 
3.5  days,  respectively.  The  instantaneous  reproduc-
tion  number,  i.e.  the  average  number  of  secondary 
cases  per  single  primary  case  at  calendar  time  t,  is 
calculated as 
  (1 ) (1 ) , tt R p p U     
            …(3) 
which is useful to objectively interpret the epidemic 
curve  in  real-time,  because  if  the  Rt  exceeds  1,  it 
clearly indicates increase in infections on day t. The 
renewal process in (1) is rewritten as 
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for unvaccinated cases, and 
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  …(5) 
for vaccinated cases. 
Due  to  enhanced  surveillance,  and  because 
measles  rarely  involves  secondary  transmissions 
arising  from  asymptomatic  or  subclinical  cases,  the 
number  of  infected  cases  is  assumed  to  have  been 
fully  captured  as  a  function  of  calendar  time.  For 
mathematical convenience, we assume that the incu-
bation period is a constant so that the epidemic curve 
can  be  theoretically  shifted  leftward  for  a  constant 
period for the purpose of statistical analysis using the 
above mentioned model. In empirical observation, a 
part of cases did not remember vaccination history. Int. J. Biol. Sci. 2012, 8 
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Assuming  that  the  past  vaccination  history  is  inde-
pendent of possessing a memory of vaccination his-
tory, the probability of knowing vaccination status, q, 
is assumed to be governed by a binomial sampling 
process  of  the  cumulative  number  of  cases  with 
known  vaccination  history  among  the  cumulative 
total of cases. Let h0,t, h1,t and h9,t denote the observed 
numbers of unvaccinated cases, vaccinated cases and 
cases  who  did  not  remember  vaccination  status  on 
day t, respectively. We assume that the observed in-
cidence with vaccination history  h0,t and h1,t are the 
results  of  Poisson  sampling  with  expected  values 
qE(j0,t;Zt-1)  and  qE(j1,t;Zt-1),  respectively,  where 
E(jx,t;Zt-1)  denotes  the  conditional  expected  value  of 
the incidence of cases with vaccination history x on 
day t given the history of observed data (i.e. h0,t, h1,t 
and h9,t) from time 0 up to (t-1), denoted by Zt-1.The 
likelihood  function  to  estimate  the  reproduction 
number for each date, R, and other parameters q and 
 is written as follows: 
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0, 1,
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The maximum likelihood estimates of R, q, and  are 
found by minimizing the  negative logarithm  of (6). 
The 95% confidence intervals are computed based on 
profile  likelihood.  Maximum  likelihood  estimation 
was  conducted  using  the  statistical  package  R 
(http://www.r-project.org/) and we used the  plkhci 
function from the Bhat package. 
Mathematical model 2: Heterogeneous popu-
lation 
Although  the  above-mentioned  model  is  kept 
simple, the empirical data suggest that the frequency 
of cases greatly differs by age (Figure 1). Differential 
frequency of cases by age may be attributable to (i) the 
differential  population  structure,  (ii)  the  different 
contact patterns, (iii) the differential protection con-
ferred by vaccination and so on. Thus we extend the 
above-mentioned  model  to  age-dependent  data  so 
that the epidemiological dynamics is better captured. 
We  take  an  approximate  approach  and  divide  the 
population into three discrete age-groups. Since the 
second-dose vaccination is scheduled by the age of 6 
years with the available social contact data categoriz-
ing  the  youngest  group  of  children  aged  from  0-4 
years, and because the adult infections may be sepa-
rated from those in children to clarify the contribution 
of schools to the epidemic, the age groups are classi-
fied as 0-4 years, 5-19 years and 20 years and above, 
respectively. The relative population sizes of the age 
group  i,  ni  are  4.9%,  15.1%  and  80.1%  in  2007  and 
4.8%, 14.8% and 80.4% in 2008, respectively. Let the 
age-specific incidence of vaccination status k and age 
group a as jka,t on day t, the dynamics is described by 
the multivariate renewal process as follows: 
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0
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for unvaccinated cases, and 
1 , 0 , 1 ,
0
(1 ) ( ) a t a a t a ab b t b t
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 ...(8) 
for vaccinated cases. Here {βij} is the normalized con-
tact  matrix  with  the  eigenvalue  1,  describing  the 
age-dependent contact frequency which  we retrieve 
from the published result of social contact survey in 
the  UK  [17].  To  address  differential  contact  rates 
across  different  age-groups,  we  assume  that  the 
age-dependent frequency in Aichi with an adjustment 
of the age-dependent population size in Japan is the 
same as that observed in the UK (Table 1). Ut repre-
sents the average number of secondary transmissions 
per single primary case at calendar time t, which is 
influenced  by  all  factors  other  than  vaccination  in-
cluding intrinsic and extrinsic ones. The instantane-
ous reproduction number is calculated as the domi-
nant eigenvalue of the 6×6 matrix derived from (7) 
and (8), the analytical solution of which is not very 
insightful in our example, and we focus on estimating 
Ut as a parameter for the heterogeneous model. The 
age-dependent vaccination coverage pa is assumed as 
known,  i.e.  97.0,  93.4  and  99.0%  for  those  aged  0-4 
years, 5-19 years, and 20 years and above, respective-
ly. The average of those coverage estimates is greater 
than that for the base-line in the homogeneous setting, 
because the coverage for adults 99.0% is not realisti-
cally  tractable  due  to  past  natural  exposures  and 
booster effect [18]. Namely, among adults we assume Int. J. Biol. Sci. 2012, 8 
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that the above mentioned coverage denotes the frac-
tion  immune  or  seropositive  based  on  serological 
survey [19]. 
Let h0a,t , h1a,t and h9a,t be the observed incidence of 
unvaccinated cases, vaccinated cases and the cases did 
not  remember  their  own  vaccination  history  in  age 
group a on day t. As discussed in the homogeneous 
case,  we  assume  that  the  vaccination  status  of  the 
cases is independent of remembering their own vac-
cination history, and we also assume that the proba-
bility of having the memory, q is independent of age. 
To estimate U, q and a, we maximize the following 
likelihood:
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where  Z  represents  the  history  of  epidemic  data 
across all age-groups. 
 
 
Table 1. The matrix describing the within and between 
age-group frequency of social contact. 
Year 2007 
Age  0-4  5-19  20 and above 
0-4  0.139  0.113  0.440 
5-19  0.037  0.633  0.532 
20 and above  0.027  0.100  0.829 
Year 2008 
Age  0-4  5-19  20 and above 
0-4  0.145  0.118  0.460 
5-19  0.038  0.600  0.561 
20 and above  0.027  0.103  0.828 
The age-groups in the first column represent those of contactee (i.e. 
those who are exposed to cases), while the age-groups in second 
and seventh rows represent those of contactor (i.e. the primary 
cases). The contact is expressed by per unit time (i.e. per day in case 
of this table), although each element is adjusted due to normaliza-
tion. 
 
 
Results 
Figure  1  shows  the  temporal  and  age-specific 
distributions of measles cases stratified by vaccination 
history.  The  epidemic  curves  in  2007  and  2008  rec-
orded the highest incidence in weeks 22 and 18, re-
spectively.  Since  there  have  been  very  few  cases 
nearby  new-year  and  year-end  days  in  both  years, 
and due to epidemic in discrete geographic locations, 
we analyzed each epidemic year separately from the 
other, while we focused on the data which combined 
both  years  when  we  estimate  the  vaccine  efficacy 
(because the vaccine efficacy is not expected to vary 
greatly by a single year due to limited antigenic di-
versity of measles and small changes in vaccination 
status in the population). The mean (and the standard 
error, SD) and median age of cases (and inter-quartile 
range) were 18.9 (13.9) and 17.0 (10.0-26.0) years in 
2007,  respectively.  Similarly,  the  mean  and  median 
were 14.2 (12.5) and 13.0 (2.0-24.0) years in 2008, re-
spectively. In both years, the cases were aggregated 
among children and very few elderly cases were ob-
served. The cases in 2008 appeared to be significantly 
younger than that in 2007 (p=0.0003, t-test). The pro-
portion  of  cases  who  remember  as  vaccinated  was 
26.9% (95%  confidence  interval  (CI): 20.9,  32.9)  and 
25.3% (95% CI: 19.2, 31.3), respectively, in 2007 and 
2008,  which  did  not  significantly  differ  by  year 
(p=0.76,  χ2  test).  The  proportion  of  cases  who  re-
membered either as vaccinated or unvaccinated was 
67.9% (95% CI: 61.6, 74.2) and 68.7% (95% CI: 62.2, 
75.1) in 2007 and 2008, respectively, which was again 
not significantly different by year (p=0.99, χ2 test).  
Figures 2 and 3 show the estimated instantane-
ous  reproduction  numbers  using  the  homogeneous 
model in 2007 and 2008, respectively, along with the 
visual  comparisons  between  the  observed  and  pre-
dicted epidemic curves with known vaccination his-
tory.  The  estimated  reproduction  numbers  in  early 
and late epidemic phases were very high, reflecting a 
mathematical property of the renewal process, i.e., in 
these time periods, the effective reproduction number 
tends to be very large due to small number of primary 
cases,  and  thus,  we  omitted  the  early  estimates  in 
Figures 2 and 3. While the majority of the maximum 
likelihood estimates of Rt fell below unity, the upper 
95%  confidence  interval  continuously  exceeded  1, 
perhaps reflecting a small number of cases (i.e. sam-
pling error) and high transmission potential of mea-
sles  with  limited  vaccination  coverage.  Analyzing Int. J. Biol. Sci. 2012, 8 
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both  years  with  assumed  common  vaccination  cov-
erage, the maximum likelihood estimates of the vac-
cine efficacy, , was estimated at 96.7% (95% CI: 95.8, 
97.4). The proportion of cases with known vaccination 
history, q, was estimated at 68.3% (95% CI: 65.1, 71.4). 
Even when we estimated   separately by 2007 and 
2008, they were not significantly different:  in 2007 
and 2008 was 96.5% (95% CI: 95.2, 97.5) and 96.8% 
(95% CI: 95.5, 97.8), respectively.  
When  we  employed  the  age-heterogeneous 
model, the vaccine efficacy was separately estimated 
for  each  age-group.  The  maximum  likelihood  esti-
mates of the vaccine efficacy 1, 2 and 3 for those 
aged 0-4 years, 5-19 years, and 20 years and above 
were 97.9% (95% CI: 95.8, 99.0), 93.4% (95% CI: 89.0, 
96.1) and 99.6% (95% CI: 99.2, 99.8), respectively. The 
proportion of cases with known vaccination history, q, 
was estimated to be 68.1% (95% CI: 65.2, 70.9). As the 
model  captures  the  time-dependency,  the  good-
ness-of-fit  and  the  estimates  of  the  reproduction 
number did not greatly differ from those shown in 
Figures 2 and 3 (Results not shown). 
Since we cannot directly estimate the exact vac-
cination coverage among those involved in the con-
tact, the sensitivity analysis was conducted (Figure 4). 
Within  the  assumed  range  of  vaccination  coverage 
(90.0%-99.5%),  the  maximum  likelihood  estimate  of 
the  vaccine  efficacy  ranged  93.3%-99.7%.  The  esti-
mated  vaccine  efficacy  increased  as  the  vaccination 
coverage increased. The reason for positive relation-
ship in Figure 4 is intuitively understood from equa-
tions (4) and (5). That is, if we take the ratio of the 
incidence of unvaccinated to vaccinated, we get 
0,
1,
11
.
1
t
t
j p
jp 



           …(10) 
The left-hand side of equation (10) corresponds to the 
observed  data  which  is  a  constant  on  a  single  day 
(given empirical data). If we increase the vaccination 
coverage  p, then (1-p)/p decreases and this necessi-
tates 1/(1-) to increase in equation (10) or forces the 
vaccine efficacy  to increase. 
 
 
Figure 1. The time and age-specific distributions of the measles outbreak in Aichi prefecture, Japan, from 2007-08. A & 
B. The temporal distribution of measles cases. The week 1 corresponds to the week that includes 1st January. C & D. The age distribution 
of measles cases. In all panels, the vaccinated and unvaccinated correspond to the cases who clearly remembered as previously vaccinated 
and unvaccinated, respectively. Unknown represents the cases who did not remember vaccination history at the time of diagnosis of 
measles. Int. J. Biol. Sci. 2012, 8 
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Figure 2. The estimated instantaneous reproduction numbers and visual comparisons between the observed and pre-
dicted temporal distributions by known vaccination history in 2007. A. The maximum likelihood estimates (circles) and the 
upper 95% confidence interval (steps) of the instantaneous reproduction number. The horizontal axis is expressed as the calendar date in 
which 1st January is set to be 0. The horizontal grey line shows the level at which Rt = 1. For mathematical reasons Rt is unrealistically high 
during the very early and late epidemic phases, and thus, the estimates are omitted from this panel. B, C and D. Comparisons between 
observed and predicted temporal distributions of cases. B and C compare cases who were known to be vaccinated and unvaccinated, 
respectively. D shows the cases who did not remember vaccination history at the time of diagnosis of measles. The week 1 corresponds 
the week that includes 1st January. 
 
Discussion 
The present study proposed a simple method to 
estimate the vaccine efficacy against measles, jointly 
quantifying  the  parameters  governing  the  temporal 
evolution of measles. The method uses only the epi-
demiological  surveillance  data  with  partial  infor-
mation of vaccination history, which can rest on read-
ily available datasets and is not as costly as conduct-
ing  specialized  field  study  such  as  that  observing 
household transmissions. To capture the realistic as-
pect  of  measles  transmission,  the  extended  model 
accounted  for  age-dependent  heterogeneity  [20-22]. 
Although not significant, the vaccine efficacy among 
those aged 5-19 years was shown to be smaller than 
that in children aged below 5 years, which may per-
haps  reflect  the  waning  immunity  among  school 
children [23]. Given Figure 4 and considering that the 
actual vaccination coverage can be lower than that in 
literature due to cessation of MMR vaccine in 1993, 
the assumed coverage of 93.4% may be suggestive of 
potential  overestimation  of  vaccine  efficacy  (if  the 
actual vaccination coverage is lower), but not of un-
derestimation.  Therefore,  the  straightforward  policy 
implication  is  that  one  may  target  school  children 
aged 5-19 for (re-)vaccination to eliminate the pockets 
of susceptible individuals. 
As the proposed method can rest on the readily 
available  data  (i.e.  routinely  collected  surveillance 
data), we believe that the model has a potential to be 
integrated  with  the  routine  surveillance  practice  of 
measles across the world. In particular, the proposed 
method permits the presence of missing data for vac-
cination history with an assumption of missing com-
pletely at random (MCAR), which has not been ex-
plicitly dealt with in earlier modeling studies. While 
various  mathematical  approaches  have  been  pro-
posed  to  model  the  measles  epidemic,  the  present 
study offered advancement in two different aspects. 
First, although many studies analyzed the transmis-
sion dynamics using mathematical models, the objec-
tives  of  those  studies  have  been  different  from  the 
efficacy  estimation,  and  they  frequently  focused  on 
the estimation of time-dependent notification charac-Int. J. Biol. Sci. 2012, 8 
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teristics [24] or clarification of the kinetics of measles 
transmission  using  mathematical  model  [25].  The 
present study has shown that the vaccine efficacy is 
very  conveniently  estimated,  assuming  that  the  de-
pletion  of  susceptible  individuals  is  negligible.  Se-
cond, whereas a few other studies estimated the vac-
cine efficacy, including that based on final size [1,4] 
and an explicit modeling of epidemic dynamics [26], 
the present study is the first to have jointly conducted 
the vaccine efficacy estimation and the real-time as-
sessment of an epidemic, by estimating the effective 
reproduction number Rt along with the vaccine effi-
cacy  parameter.  In  other  words,  our  proposed  ap-
proach  not  only  helps  assess  vaccine  efficacy  but 
permits us to interpret the temporal evolution in an 
objective manner. 
 
Figure 3. The estimated instantaneous reproduction numbers and visual comparisons between the observed and pre-
dicted temporal distributions by known vaccination in 2008. A. The maximum likelihood estimates (circles) and the upper 95% 
confidence interval (steps) of the instantaneous reproduction number. The horizontal axis is expressed as the calendar date in which 1st 
January is set to be 0. The horizontal grey line shows the level at which Rt = 1. For mathematical reasons Rt is unrealistically high during the 
very early and late epidemic phases, and thus, the estimates are omitted from this panel. B, C and D. Comparisons between observed and 
predicted temporal distributions of cases. B and C compare cases who were known to be vaccinated and unvaccinated, respectively. D 
shows the cases who did not remember vaccination history at the time of diagnosis of measles. The week 1 corresponds the week that 
includes 1st January. 
 
 
 
Figure 4. Sensitivity of vaccine efficacy to the vaccination cov-
erage.  Solid  line  represents  the  maximum  likelihood  estimate,  while 
dashed lines are the upper and lower 95% confidence intervals of vaccine 
efficacy. The 95% confidence intervals were derived from profile likeli-
hood.  Although  we  show  the  results  from  homogeneous  model,  the 
qualitative patterns of age-heterogeneous model are not different. 
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However, the following three remarks should be 
noted as technical limitations. First, we successfully 
estimated the vaccine efficacy as well as Rt, but we did 
so  assuming  that  the  depletion  of  susceptible  indi-
viduals is negligible. We believe that this assumption 
is  reasonable  because  the  number  of  cases  in  Aichi 
remained very small as compared to the population 
size of unvaccinated individuals who can be theoret-
ically  considered  as  fully  susceptible  [27],  and  also 
because the epidemic data in question were seen in a 
population  which  was  large  enough.  However,  the 
model cannot capture detailed heterogeneous trans-
mission  such  as  local  depletion  of  susceptible  indi-
viduals (e.g. due to formation of a cluster) and thus, 
the proposed method may not be directly applicable 
to outbreaks in a very small population. Second, we 
did not account for detailed revaccination schedules 
in Japan due to impossibility of precisely tracking the 
fraction of unvaccinated susceptible individuals as a 
function  of  age.  The  number  of  doses  may  have  a 
profound  impact  on  vaccine  efficacy,  but  unfortu-
nately we did not have access to the dose data for each 
confirmed case. Third, the proposed model assumes a 
closed  population,  i.e.,  without  emigration  and  im-
migration.  However,  obviously  the  observed  data 
must have involved imported cases. From modeling 
perspectives, the host migration has little impact on 
the estimate of vaccine efficacy, while it would influ-
ence the estimates of Rt [28]. Given the individual case 
record for the entire country in the future, one can 
analyze  the  dynamics,  explicitly  accounting  for  the 
geographic spread of measles across Japan. 
Despite such limitations, we believe that the re-
al-time  assessment  of  epidemic  dynamics  with 
(age-specific) estimates of  vaccine efficacy based on 
readily available surveillance datasets would be the 
huge  advantage  for  epidemiological  monitoring  of 
measles in any vaccination population. As was seen in 
age-dependent vaccine efficacy, the proposed method 
could inform useful vaccination policy to objectively 
curb  the  measles  epidemic  in  real-time.  If  measles 
vaccination  is  compulsory,  the  finding  will  directly 
lead  to  deciding  the  host  for  revaccination,  and  if 
voluntary, the self- and group-interests may have to 
be balanced [29-31]. At the very least, we believe that 
the proposed approach can supplement the existing 
evaluation methods of vaccine efficacy. 
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